iRhythm price target raised to $135 from $120 at BTIG
BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $135 from $120 and keeps a Buy rating on the shares after its ...
Yahoo Finance3d
BTIG upgrades Snowflake to 'buy' on improving demand
Investing.com -- BTIG upgraded Snowflake Inc (NYSE:SNOW) to "Buy" from "Neutral" and introduced a $220 price target on improving demand trends and potential AI-driven growth. The brokerage noted ...
The Wall Street Transcript3d
Shopping Center REIT Has Strong Track Record, Best-in-Class Portfolio
When we spoke three years ago, your research was focused on the shopping center, net lease and health care subsectors. Is there anything new or different about your coverage universe here in 2025? Mr.
Guardant Health price target raised to $60 from $55 at BTIG
BTIG raised the firm’s price target on Guardant Health (GH) to $60 from $55 and keeps a Buy rating on the shares after its Q4 earnings beat and ...
Morningstar19d
BTIG to Host Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference on February 11 - 12, 2025
For more information about the conference, email uscorporateaccess@btig.com. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a BTIG ...
Watch out for Wednesday's expiration of VIX options
Futures and options on the Cboe Volatility Index, the options-derived measure of expected volatility on the S&P 500, expire ...
BTIG Sticks to Its Buy Rating for Zealand Pharma (ZLDPF)
In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Zealand Pharma (ZLDPF – Research Report), with a price ...